Erratum: Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): An open-label, randomised, multicentre phase 2 trial (Lancet (2010) 376 (705-716))

The Lancet

Volumn 376, Issue 9748, 2010, Pages 1224-

  Kwo, P Y ^a   Lawitz, E J ^a   McCone, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERRATUM; ERROR; PRIORITY JOURNAL;

EID: 77957978374     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61881-8     Document Type: Erratum

References (0)